INS and hyperinsulinism: Insulin-sensitive and insulin-resistant states are mediated by tyrosine protein phosphatase nonreceptor type 6 protein (PTPN6), and reducing PTPN6 expression can modulate immune system dysfunction and insulin resistance caused by hyperinsulinemia [51].